On 15 November 2016, the European Commission (“the Commission”) opened its second report on Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use, as last amended (“the Paediatric Regulation” or “the Regulation”) for public consultation. The consultation deadline for the draft report
More Posts
EMA revises Guideline on First-in-Human Trials
ANSM on the de-notification or termination of notified bodies’ activities
Ninth Research Framework Programme (FP9) in preparation
EMA on CVMP strategy on antimicrobials 2016-2020
EMA opens public consultation on ICH E11(R1) Guideline
EMA Management Board progresses on New Medicines Web Portal
EMA and FDA set up new working group on rare diseases
EMA determines plasma- and urine- derived medicines safe from Zika contamination
EMA to Revise Herbal Medicines Guideline
Subscribe: Subscribe via RSS
Blogs
Firm/Org